Anaqua and Clarivate (CPA Global) Alternatives for India (2026)

Buyer’s Guide · IP Management Systems

Updated for 2026 · Claw Editorial

If your renewal notice still says "CPA Global" on it, the company you think you are dealing with has not existed as an independent business for years, and the vendor you actually have a contract with has been through more ownership changes since. That matters for a very practical reason: before you can even ask "what should I switch to", you need to know which product you are on, who owns it today, and how stable that is likely to stay. This guide covers that consolidation in plain terms, then looks at the India-native alternatives worth evaluating alongside it.

01Why "CPA Global" is a confusing name now

CPA Global stopped being an independent company when Clarivate completed its acquisition of it on 1 October 2020. Everything that was once sold under the CPA Global name is now part of Clarivate’s Intellectual Property segment. So when someone says "we use CPA Global", the honest first question is: which product, exactly?

One name, several different systems

CPA Global itself sold five core platforms built for different buyers: FoundationIP (a hosted solution for corporates and law firms), Inprotech (built for law-firm clients), Ipendo (a lighter, cloud-based option for small corporate teams), Memotech (corporate IP departments), and Patrawin. A separate product, Unycom, joined the stable through CPA Global’s 2019 merger with the ipan Delegate Group, and is now sold as "Unycom by Clarivate". IPfolio, a cloud-native IP management system, is also now part of Clarivate, though its exact acquisition history sits outside CPA Global’s own lineage. A team that says "we are on CPA Global" could mean any one of these, each with a different interface, a different renewal cycle, and a different migration path if you decide to leave.

The name confusion is not the real problem

The real problem is that this is what industry consolidation looks like from the buyer’s side: products get folded into a bigger portfolio, roadmaps get rationalised, and pricing and support terms change at renewal, often without a clear announcement to every customer. Anaqua, the main rival to Clarivate’s IP business, has been through the same pattern from a different direction, acquiring smaller vendors rather than being acquired. Both are covered in the next section.

02Where Clarivate and Anaqua stand today

Both incumbents have been through significant change in the last eighteen months, and a buyer evaluating either one should know the shape of it.

Clarivate: a large, but not fast-growing, IP business

Clarivate’s Intellectual Property segment, built substantially on the old CPA Global business, is a large part of Clarivate’s overall revenue, but its own reporting shows growth has gone flat to declining rather than expanding: organic re-occurring revenue in the segment fell and organic transactional revenue fell further in 2025, by Clarivate’s own account. The segment has also changed leadership twice in less than a year. Maroun Mourad took over as IP segment president in September 2025, then Clarivate announced in mid-2026 that Simon Webster, CPA Global’s own chief executive from 2015 to 2021, would return to lead the segment from 10 June 2026. Separately, in July 2026 Clarivate agreed to sell its Life Sciences & Healthcare segment to Altaris for $600 million and said it would focus on its two remaining segments, Academia & Government and Intellectual Property, which is a useful data point for anyone wondering whether Clarivate is stepping back from IP: on the public record, it is doing the opposite.

Anaqua: a private-equity-backed acquisition run

Anaqua has taken a different path. Nordic Capital, a private equity investor, completed its acquisition of Anaqua from Astorg on 25 February 2025, and has since backed a run of further acquisitions: RightHub, an AI-native IP platform aimed at mid-size law firms and corporates, on 15 May 2025, and Patrix, owner of the thirty-year-old Patricia docketing platform used by nearly 400 law firms, on 28 April 2026. Anaqua’s own core products are AQX and PATTSY WAVE, an integrated docketing platform aimed at IP operations teams. PATTSY WAVE is an Anaqua product, not an independent company or an alternative to Anaqua; it is one of the platforms inside the same portfolio.

What this means for a buyer

Both incumbents are consolidating rather than shrinking, and that is the risk worth naming plainly: every acquisition brings a legacy platform (FoundationIP, Inprotech, Patrawin, RightHub, Patricia) whose long-term roadmap is now decided by someone other than the team you originally signed with. Before renewing or switching, it is worth negotiating specific protections into the contract: a defined notice period if your specific platform is sunset or merged into another one, a cap on price increases at renewal, a written commitment to data export in a usable format, and a migration-assistance clause that survives any future acquisition of the vendor. None of this is unusual to ask for. It is unusual for buyers to ask for it before signing, rather than after an acquisition is announced.

Both Clarivate and Anaqua are consolidating, not standing still. The contract you sign should assume your vendor will change hands again.

03Six tests before you sign or switch

Most Anaqua and Clarivate marketing is written for a global, multi-jurisdiction buyer. If your portfolio is India-heavy, or wholly India-based, run any option, incumbent or alternative, through these six India-specific checks before you commit.

• IP India and InPASS sync: does the system pull live status updates directly from the Indian Patent Office’s InPASS system, or does someone have to check and re-enter status by hand?
• Trade Marks Registry coverage: does it track applications, oppositions, and Trade Marks Journal publication against the actual Registrar of Trade Marks records, not just a generic docket entry?
• Delhi High Court IP Division linkage: for matters that reach litigation, can the tool show hearings, orders, and cause lists for the Delhi High Court’s IP Division and other courts’ IP-related benches, or does that require a separate tool entirely?
• Statutory deadline calculation: does it correctly calculate India-specific deadlines, such as the four-month window to oppose a published trademark, or a patent annuity and response deadline under the Patents Act and Rules, rather than a generic global default?
• Migration: what does moving years of docket history in or out of the platform actually involve in practice: file format, timeline, and who does the work?
• Data residency: where is the underlying data hosted, and does that meet what your organisation expects for Indian client and portfolio data?

These are not abstract questions. A tool that answers all six clearly is doing genuine India-specific work, not just adding an India entry to a global drop-down list. For a broader framework on separating a vendor’s marketing claims from what it can actually demonstrate, see how to evaluate a vendor’s litigation data claims.

04India-first alternatives, ranked

Ranked here for the specific job of running an India-centric IP portfolio, meaning registry tracking, gazette watch, statutory compliances, and court-side litigation, not for global multi-jurisdiction enterprise docketing. On that different, larger job, Anaqua and Clarivate still lead, and that concession is made honestly rather than argued around.

05The unbundling option most buyers miss

Most Anaqua and Clarivate contracts sell docketing, annuity and renewal payment handling, and registry or gazette watch as one bundle. Few Indian buyers stop to ask whether they actually need all three from the same vendor. In practice, these are three separable purchases, and unbundling them can both cut cost and fix the "one vendor, one weak spot" problem that comes from a single system trying to do everything at once.

Unbundling has a real trade-off: one vendor and one invoice is administratively simpler than three. But for a purely India-based portfolio, the bundle you are paying for from Anaqua or Clarivate is priced and built for global-scale docketing, and the registry-watch and court-litigation legs of that bundle are often the weakest part of it for India specifically. Buying those two pieces from an India-native provider, while keeping docketing or annuities with the incumbent if that relationship is working, is a legitimate middle path.

06Side-by-side comparison

07How to choose

Start from the shape of your portfolio, not from brand familiarity.

If most of your filings and disputes are India-based, run any candidate, Claw included, through the six tests above before you sign anything. An India-centric all-in-one option is worth serious consideration here, because the global platforms are priced and built for a different scale of problem. If you manage a genuine multi-jurisdiction portfolio with filings across many countries, Anaqua or Clarivate remain the safer foundation for docketing and annuities, and no India-native tool on this page claims to replace that. If you are already on Anaqua or a Clarivate legacy platform and simply want to fix the weakest part of it, the unbundling table above is the more useful exercise than a full switch: keep what works, and add an India-native registry-watch or litigation-tracking layer for the part that does not.

It also helps to be clear on what you are actually buying in the first place. Registry docketing, litigation tracking, and general practice management sound similar but solve different problems, and mixing them up is a common procurement mistake. See case tracking vs practice management software for that distinction before you shortlist vendors.

08Where Claw fits

Claw is an all-in-one legaltech platform for Indian advocates, law firms, and corporate legal teams, combining AI-based case search, an AI legal assistant (Legal GPT), case management, and compliance automation across all Indian courts and tribunals.

Claw is not a global enterprise IPMS, and it is not trying to be. It does not do multi-jurisdiction docketing across dozens of countries, it does not remit annuity payments, and for a corporate with filings spread across the US, Europe, and Asia, Anaqua or Clarivate remain the right foundation for that global leg. Where Claw earns its place is the India-centric job: its IPR Solutions tab tracks trademark, patent, design, and GI matters against IP India directly, including gazette and Trade Marks Journal publication monitoring that flags conflicting marks and alerts the user, pending compliances such as trademark renewals and patent annuity and response deadlines, and pending hearings arising from those filings. Alongside that registry side, Claw tracks IP litigation across every Indian court with a case website, covering party-name infringement discovery and IP Division hearings, orders, and cause lists, and layers AI judgement research over 30 crore-plus judgements on top. The one honest gap is copyright: Claw does not yet track copyright registration with the separate Copyright Office, and covers the court side only there. Because IP disputes often involve sensitive, unpublished filings, it is also worth being clear that Claw does not use customer case documents to train its AI models. For a direct comparison against the global incumbent, see Claw vs Anaqua, and against the closest India-native docketing specialist, Claw vs Iolite.

09Sources and further reading

The vendors and filings discussed here, linked to their official sources:

• Anaqua: anaqua.com
• Clarivate: clarivate.com
• Nordic Capital (Anaqua ownership): nordiccapital.com
• SEC EDGAR (Clarivate filings): sec.gov
• Iolite: iolitesoftwares.com
• Provakil: provakil.com
• Legistify: legistify.com
• Claw: clawlaw.in
• IP India (Office of the Controller General of Patents, Designs and Trade Marks): ipindia.gov.in

This is not an exhaustive list of vendors. Corporate ownership, pricing, and feature depth change, and should be confirmed directly with each vendor and with primary filings before you buy.

10Frequently asked questions